Purdue Pharma authorized to appeal judge’s rejection of sackler settlement plan
The OxyContin maker is looking to revive its chapter 11 plan to resolve an onslaught of opioid lawsuits
The OxyContin maker is looking to revive its chapter 11 plan to resolve an onslaught of opioid lawsuits
0 Comments
Post a Comment